Benedicte Deau-Fischer
6PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 26, 2023
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM).Marion Detroit, Mathis Collier, Nathanaël Beeker
|May 16, 2023
Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA.A Marouf, N Molinari, D Sibon
|Nov 11, 2022
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era.Jeremie Zerbit, Marion Detroit, Antoine Meyer
|Apr 21, 2022
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA).Guillaume Manson, Charles Herbaux, Jean-Marc Schiano
|Jun 20, 2019
Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study.Johanna Mondesir, Anne-Sophie Alary, David Sibon
|Apr 04, 2018
Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study.Benedicte Deau, Sandy Amorim, Aurore Perrot
Pageof 1
Frequent Collaborators
2 joint publications
David Sibon
2 joint publications
Hervé Ghesquieres
2 joint publications
Rui Batista
1 joint publications
A Marouf
1 joint publications
C Herbaux
1 joint publications
C Rossi
1 joint publications
Olivier Tournilhac
1 joint publications
Jerome Tamburini
1 joint publications
Guillaume Manson
1 joint publications
Aspasia Stamatoullas
